News
Leibniz drug of the year 2020 comes from Jena
Malleicyprols involved in life-threatening diseases more… Leibniz drug of the year 2020 comes from Jena
Firmen laufen weiter
Running „Corona Style“ more… Firmen laufen weiter
Protein increases risk of age-related visual impairment
Better risk assessment and targeted therapies possible more… Protein increases risk of age-related visual impairment
Cancer: Study suggests that gut microbiome can provide prognosis for therapy
Possible correlation between success of cancer therapy and intestinal microbes more… Cancer: Study suggests that gut microbiome can provide prognosis for therapy
Spider bite leads to new active compounds
International research team gets to the root of infection more… Spider bite leads to new active compounds
The map to the natural product treasure trove
Leibniz-HKI scientists develop a model of the evolution of biosynthetic pathways more… The map to the natural product treasure trove
When magic mushrooms turn blue
Scientists from Jena investigated the blue coloration of magic mushrooms after injury more… When magic mushrooms turn blue
Tuberculosis: New active substance BTZ-043 is being tested on patients for the first time
A crucial step in the development of a promising new drug in preclinical tests more… Tuberculosis: New active substance BTZ-043 is being tested on patients for the first time
Scientific Excellence at the Leibniz-HKI
Miriam Rosenbaum receives an ERC Consolidator Grant more… Scientific Excellence at the Leibniz-HKI
